Nicox S.A. (OTCMKTS:NICXF) Short Interest Update

Nicox S.A. (OTCMKTS:NICXF) saw a significant decline in short interest during the month of February. As of February 15th, there was short interest totalling 54,900 shares, a decline of 20.3% from the January 31st total of 68,900 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.

Nicox Stock Performance

Shares of OTCMKTS:NICXF remained flat at $0.28 on Tuesday. The business has a fifty day simple moving average of $0.24 and a 200 day simple moving average of $0.33. Nicox has a 12-month low of $0.24 and a 12-month high of $0.28.

Nicox Company Profile

Nicox SA operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial.